New Data Platform Tracks Complex Path To Alzheimer's
This image was generated by AI and may not depict real events.
A new data platform, the M3AD Study and Real-World Data Metaplatform, has been developed to track the complex path to Alzheimer's disease. The platform uses electronic health records from approximately 60,000 individuals with Alzheimer's disease and related dementias to analyze how multiple chronic diseases, behaviors, and social conditions interact over time to shape dementia risk.
Researchers at Columbia University have developed a new data platform to study Alzheimer's disease. The platform uses electronic health records from three US cities, including New York City, Chicago, and Miami. It analyzes interacting health conditions, behaviors, and social factors simultaneously and over time. The study draws on data from nearly 10 million patients, including 60,000 with Alzheimer's disease and related dementias. The platform aims to improve predictions of dementia risk and progression. The research is motivated by the growing scale of dementia in the US, with over 7.2 million older Americans living with Alzheimer's disease.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.